Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053557 | SCV001217825 | uncertain significance | Bloom syndrome | 2019-03-22 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with BLM-related conditions. This sequence change replaces proline with alanine at codon 1412 of the BLM protein (p.Pro1412Ala). The proline residue is moderately conserved and there is a small physicochemical difference between proline and alanine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001053557 | SCV002090674 | uncertain significance | Bloom syndrome | 2018-09-22 | no assertion criteria provided | clinical testing |